References

  1. Wagner FF et al. Frequencies of the blood groups ABO, Rhesus, D category VI, Kell, and of clinically relevant high-frequency antigens in south-western Germany. Infusionsther Transfusionsmed, 1995. [Citation] [RHeference]
  2. Flegel WA et al. RHD epitope density profiles of RHD variant red cells analyzed by flow cytometry. Transfus Clin Biol, 1996. [Citation] [RHeference]
  3. Gassner C et al. RHD/CE typing by polymerase chain reaction using sequence-specific primers. Transfusion, 1997. [Citation] [RHeference]
  4. Avent ND et al. Molecular basis of the D variant phenotypes DNU and DII allows localization of critical amino acids required for expression of Rh D epitopes epD3, 4 and 9 to the sixth external domain of the Rh D protein. Br J Haematol, 1997. [Citation] [RHeference]
  5. Wagner FF et al. Three molecular structures cause rhesus D category VI phenotypes with distinct immunohematologic features. Blood, 1998. [Citation] [RHeference]
  6. Wagner FF et al. Molecular basis of weak D phenotypes. Blood, 1999. [Citation] [RHeference]
  7. Wagner FF et al. Weak D alleles express distinct phenotypes. Blood, 2000. [Citation] [RHeference]
  8. Flegel WA et al. Primary anti-D immunization by weak D type 2 RBCs. Transfusion, 2000. [Citation] [RHeference]
  9. Wagner FF et al. RHD gene deletion occurred in the Rhesus box. Blood, 2000. [Citation] [RHeference]
  10. Wagner FF et al. A D(V)-like phenotype is obliterated by A226P in the partial D DBS. Transfusion, 2001. [Citation] [RHeference]
  11. Müller TH et al. PCR screening for common weak D types shows different distributions in three Central European populations. Transfusion, 2001. [Citation] [RHeference]
  12. Wagner FF et al. RHD positive haplotypes in D negative Europeans. BMC Genet, 2001. [Citation] [RHeference]
  13. Wagner FF et al. DNB: a partial D with anti-D frequent in Central Europe. Blood, 2002. [Citation] [RHeference]
  14. Flegel WA et al. Section 1B: Rh flow cytometry. Coordinator's report. Rhesus index and antigen density: an analysis of the reproducibility of flow cytometric determination. Transfus Clin Biol, 2002. [Citation] [RHeference]
  15. Wagner FF et al. The DAU allele cluster of the RHD gene. Blood, 2002. [Citation] [RHeference]
  16. Wagner FF et al. The RHCE allele ceRT: D epitope 6 expression does not require D-specific amino acids. Transfusion, 2003. [Citation] [RHeference]
  17. Wagner FF et al. RHD allele distribution in Africans of Mali. BMC Genet, 2003. [Citation] [RHeference]
  18. Doescher A et al. Weak D type 1.1 exemplifies another complexity in weak D genotyping. Transfusion, 2005. [Citation] [RHeference]
  19. Chen Q et al. Random survey for RHD alleles among D+ European persons. Transfusion, 2005. [Citation] [RHeference]
  20. Denomme GA et al. Partial D, weak D types, and novel RHD alleles among 33,864 multiethnic patients: implications for anti-D alloimmunization and prevention. Transfusion, 2005. [Citation] [RHeference]
  21. Luettringhaus TA et al. An easy RHD genotyping strategy for D- East Asian persons applied to Korean blood donors. Transfusion, 2006. [Citation] [RHeference]
  22. Flegel WA et al. The RHCE allele ceCF: the molecular basis of Crawford (RH43). Transfusion, 2006. [Citation] [RHeference]
  23. Chen Q et al. The RHCE allele ceSL: the second example for D antigen expression without D-specific amino acids. Transfusion, 2006. [Citation] [RHeference]
  24. Flegel WA et al. How I manage donors and patients with a weak D phenotype. Curr Opin Hematol, 2006. [Citation] [RHeference]
  25. Flegel WA et al. In-frame triplet deletions in RHD alter the D antigen phenotype. Transfusion, 2006. [Citation] [RHeference]
  26. Yu X et al. Outliers in RhD membrane integration are explained by variant RH haplotypes. Transfusion, 2006. [Citation] [RHeference]
  27. Esteban R et al. The D category VI type 4 allele is prevalent in the Spanish population. Transfusion, 2006. [Citation] [RHeference]
  28. von Zabern I et al. IVS5-38del4 deletion in the RHD gene does not cause a DEL phenotype: relevance for RHD alleles including DFR-3. Transfusion, 2007. [Citation] [RHeference]
  29. Flegel WA et al. DCS-1, DCS-2, and DFV share amino acid substitutions at the extracellular RhD protein vestibule. Transfusion, 2008. [Citation] [RHeference]
  30. Flegel WA et al. D variants at the RhD vestibule in the weak D type 4 and Eurasian D clusters. Transfusion, 2009. [Citation] [RHeference]
  31. Flegel WA et al. Six years' experience performing RHD genotyping to confirm D- red blood cell units in Germany for preventing anti-D immunizations. Transfusion, 2009. [Citation] [RHeference]
  32. Schmid P et al. Specific amino acid substitutions cause distinct expression of JAL (RH48) and JAHK (RH53) antigens in RhCE and not in RhD. Transfusion, 2010. [Citation] [RHeference]
  33. Wagner FF and Flegel WA et al. The Human RhesusBase Online ressource, 2011. — Online ressource — [RHeference]
  34. von Zabern I et al. DFR-5 is a New Member in the DFR Family of Partial D and Has the Hybrid Structure RHD-CE(3-4)-D Transfus Med Hemother, 2012. — Abstract — [RHeference]
  35. Flegel WA et al. Allo- and autoanti-D in weak D types and in partial D. Transfusion, 2012. [Citation] [RHeference]
  36. Orzińska A et al. RHD variants in Polish blood donors routinely typed as D-. Transfusion, 2013. [Citation] [RHeference]
  37. von Zabern I et al. D category IV: a group of clinically relevant and phylogenetically diverse partial D. Transfusion, 2013. [Citation] [RHeference]
  38. Wagner FF et al. The Rhesus Site. Transfus Med Hemother, 2014. [Citation] [RHeference]
  39. Flegel WA et al. Phasing-in RHD genotyping. Arch Pathol Lab Med, 2014. [Citation] [RHeference]
  40. Sandler SG et al. It's time to phase in RHD genotyping for patients with a serologic weak D phenotype. College of American Pathologists Transfusion Medicine Resource Committee Work Group. Transfusion, 2015. [Citation] [RHeference]
  41. Srivastava K et al. The DAU cluster: a comparative analysis of 18 RHD alleles, some forming partial D antigens. Transfusion, 2016. [Citation] [RHeference]
  42. Ouchari M et al. Serologic and molecular characterization of weak D type 29. Transfusion, 2017. [Citation] [RHeference]
  43. Srivastava K et al. Two large deletions extending beyond either end of the RHD gene and their red cell phenotypes. J Hum Genet, 2018. [Citation] [RHeference]
  44. Ouchari M et al. Transfusion strategy for weak D Type 4.0 based on RHD alleles and RH haplotypes in Tunisia. Transfusion, 2018. [Citation] [RHeference]
  45. Srivastava K et al. Two distinct RHCE alleles in cis to weak D type 31 alleles in individuals from different ethnicities. Transfusion, 2018. [Citation] [RHeference]
  46. Sandler SG et al. Does transfusion of Asian-type DEL red blood cells to D- recipients cause D alloimmunization? Transfusion, 2019. [Citation] [RHeference]
  47. Flegel WA et al. A proposal for a rational transfusion strategy in patients of European and North African descent with weak D type 4.0 and 4.1 phenotypes. Blood Transfus, 2019. [Citation] [RHeference]
  48. Srivastava K et al. NG_007494.1(RHD):c.[4A>T;5G>C;6_7insG] with an RhD-negative phenotype. Transfusion, 2020. [Citation] [RHeference]